AI
IBBQ icon

Atria Investments’s Invesco NASDAQ Biotechnology ETF IBBQ Stock Holding History

Atria Investments’s Portfolio IBBQ Stock Details IBBQ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-9,979
Closed -$211K – 2088
2025
Q2 		$211K Buy
+9,979
New +$205K ﹤0.01% 1897

Other funds holding IBBQ

Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
KAM
Knightsbridge Asset Management Newport Beach, California $743M AUM 28.33% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
GM
GeoWealth Management Chicago, Illinois $2.78B AUM 15.76% 1-Year Est. Return
PCIG
Partners Capital Investment Group Boston, Massachusetts $2.65B AUM 16.42% 1-Year Est. Return
RWML
RAFFA WEALTH MANAGEMENT, LLC Washington, District of Columbia $793M AUM 13.11% 1-Year Est. Return
BI
Beckerman Institutional Ocean Grove, New Jersey $188M AUM 15.07% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Atria Investments's IBBQ Position: Q3 2025 in Review

Atria Investments sold out of Invesco NASDAQ Biotechnology ETF (IBBQ) in Q3 2025, closing a stake of 9,979 shares — an estimated $211K sold.

Atria Investments first reported a position in IBBQ in Q2 2025 and held it in 1 quarter. The position peaked at $211K in Q2 2025. 20 funds tracked by Wall St. Rank hold IBBQ as of Q3 2025.

  • Atria Investments reported no remaining Invesco NASDAQ Biotechnology ETF position as of Q3 2025 after selling out during the quarter.
  • Atria Investments sold 9,979 Invesco NASDAQ Biotechnology ETF shares in Q3 2025, an estimated $211K.
  • Atria Investments first reported a position in Invesco NASDAQ Biotechnology ETF in Q2 2025 and held it in 1 quarter.
  • Atria Investments's Invesco NASDAQ Biotechnology ETF position peaked at $211K in Q2 2025.
  • 20 funds tracked by Wall St. Rank held Invesco NASDAQ Biotechnology ETF as of Q3 2025.

Based on Atria Investments's 13F filing for Q3 2025, filed 6 Nov 2025.